Persistent URL of this record https://hdl.handle.net/1887/3593835
Documents
-
- Download
- Plos_One_17_11
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-alpha/gamma agonist aleglitazar
- All authors
- Grobbee, E.J.; Jong, V.D. de; Schrieks, I.C.; Tushuizen, M.E.; Holleboom, A.G.; Tardif, J.C.; Lincoff, A.M.; Schwartz, G.G.; Cabezas, M.C.; Grobbee, D.E.
- Date
- 2022-11-15
- Journal
- PLoS ONE
- Volume
- 17
- Issue
- 11